Artiva Biotherapeutics, Inc. ARTV Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Gilead SciencesGILD

$26.25B+5.2%

Kyverna Therapeutics, Inc.KYTX

$9.16M+32.1%

Immix Biopharma, Inc.IMMX

$1.04M-2.0%

ImmunityBio, Inc.IBRX

$445.39M+32.2%

Cullinan Therapeutics, Inc.CGEM

$2.07M+36.3%

FAQ

What is Artiva Biotherapeutics, Inc.'s total debt?

Artiva Biotherapeutics, Inc. (ARTV) reported total debt of $9.85M in Q2 2026.

How has Artiva Biotherapeutics, Inc.'s total debt changed year-over-year?

Artiva Biotherapeutics, Inc.'s total debt decreased by 25.5% year-over-year, from $13.22M to $9.85M.

What is the long-term trend for Artiva Biotherapeutics, Inc.'s total debt?

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s total debt has grown at a -19.6% compound annual growth rate (CAGR), from $16.91M to $10.94M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.